Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 3

Positive correlation of galanin with insulin resistance and triglyceride levels in obese children

Pages
560–568
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study suggests that galanin is associated with glucose homeostasis and lipidmetabolism in childhood obesity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Galanin is a neuropeptide that is shown to be involved in the regulation of food intake and glucose homeostasis.
📊
Key Findings & Data:Theobjective of this study was to evaluate the relation of serum galanin levels with anthropometric and metabolic parameters in obese andhealthy children.Material and methods: The cross-sectional study consisted of 38 obese children (mean age: 11.9 ± 3.0 years) and 30 healthy children(mean age: 11.4 ± 2.0 years).
💡
Conclusion & Impact:This study suggests that galanin is associated with glucose homeostasis and lipidmetabolism in childhood obesity.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Galanin is a neuropeptide that is shown to be involved in the regulation of food intake and glucose homeostasis. Theobjective of this study was to evaluate the relation of serum galanin levels with anthropometric and metabolic parameters in obese andhealthy children.Material and methods: The cross-sectional study consisted of 38 obese children (mean age: 11.9 ± 3.0 years) and 30 healthy children(mean age: 11.4 ± 2.0 years). Clinical and biochemical parameters [glucose, insulin, homeostasis model assessment-insulin resistance(HOMA-IR), lipids, galanin, and leptin levels] were assessed.Results: Serum galanin and leptin levels were significantly higher in obese children. In obese children, galanin levels were positivelycorrelated with fasting glucose (r = 0.398, p = 0.013), insulin (r = 0.383, p = 0.018), HOMA-IR (r = 0.375, p = 0.020), and triglycerides(r = 0.391, p=0.015). Multivariate backward regression analysis revealed that galanin levels were significantly associated with fastingglucose, insulin, HOMA-IR, and triglyceride, which explained 42.0% of the variance (r2 = 0.483, P < 0.001).Conclusions: Serum galanin levels were significantly higher in obese children than healthy controls and positively correlated withinsulin resistance and triglycerides in obese children. This study suggests that galanin is associated with glucose homeostasis and lipidmetabolism in childhood obesity.

🔖

Cite This Article

KÜME, T., DEMİR, K., BÖBER, E., ABACI, A., PAKETÇİ, A., ACAR, S., ÇALAN, Ö. G. (2022). Positive correlation of galanin with insulin resistance and triglyceride levels in obese children. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 560–568. https://ajindex.com/articles/610209

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 2011; 96: 669-673.
  2. Mishra AK, Dubey V, Ghosh AR. Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metabolism 2016; 65: 48-65.
  3. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007; 132: 2116-2130.
  4. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-128.
  5. Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, Bo P. Galanin peptide family as a modulating target for contribution to metabolic syndrome. Gen Comp Endocrinol 2012; 179: 115- 120. Fang P, Yu M, Guo L, Bo P, Zhang Z, Shi M. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides 2012; 36: 331-339.
  6. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide’s effects in the brain. Peptides 1990; 11: 995-1001.
  7. Poritsanos NJ, Mizuno TM, Lautatzis ME, Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond) 2009; 33: 1381-1389.
  8. Tempel DL, Leibowitz KJ, Leibowitz SF. Effects of PVN galanin on macronutrient selection. Peptides 1988; 9: 309-314.
  9. Adams AC, Clapham JC, Wynick D, Speakman JR. Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J Neuroendocrinol 2008; 20: 199- 206. Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci 1993; 5: 1528-1533.
  10. Baranowska B, Wasilewska-Dziubinska E, Radzikowska M, Plonowski A, Roguski K. Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism 1997; 46: 1384-1389.
  11. Fang P, Bo P, Shi M, Yu M, Zhang Z. Circulating galanin levels are increased in patients with gestational diabetes mellitus. Clin Biochem 2013; 46: 831-833.
  12. Legakis I, Mantzouridis T, Mountokalakis T. Positive correlation of galanin with glucose in type 2 diabetes. Diabetes Care 2005;28:759-760.
  13. Zhang Z, Gu C, Fang P, Shi M, Wang Y, Peng Y, Bo P, Zhu Y. Endogenous galanin